Cart
sales@molnova.com
Mogrol
CAS No. 88930-15-8
Mogrol( —— )
Catalog No. M24913 CAS No. 88930-15-8
Mogrol is a biometabolite of mogrosides. Mogrol acts via inhibition of the ERK1/2 and STAT3 pathways, or reducing CREB activation and activating AMPK signaling.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 140 | In Stock |
|
| 10MG | 237 | In Stock |
|
| 25MG | 475 | In Stock |
|
| 50MG | 671 | In Stock |
|
| 100MG | 896 | In Stock |
|
| 500MG | 1791 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMogrol
-
NoteResearch use only, not for human use.
-
Brief DescriptionMogrol is a biometabolite of mogrosides. Mogrol acts via inhibition of the ERK1/2 and STAT3 pathways, or reducing CREB activation and activating AMPK signaling.
-
DescriptionMogrol is a biometabolite of mogrosides. Mogrol acts via inhibition of the ERK1/2 and STAT3 pathways, or reducing CREB activation and activating AMPK signaling.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetERK
-
RecptorERK1| ERK2| STAT3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number88930-15-8
-
Formula Weight476.74
-
Molecular FormulaC30H52O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:110 mg/mL?(230.74 mM;?Need ultrasonic)
-
SMILESCC1(C)[C@@H](O)CC[C@@]2([H])[C@]3(C)[C@H](O)C[C@]4(C)[C@@H]([C@H](C)CC[C@@H](O)C(C)(O)C)CC[C@](C)4[C@]3([H])CC=C12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Liu C, et al. Mogrol represents a novel leukemia therapeutic, via ERK and STAT3 inhibition. Am J Cancer Res. 2015 Mar 15;5(4):1308-18.
molnova catalog
related products
-
BIX02188 (c)
BIX02188 is a selective inhibitor of MEK5 with IC50 of 4.3 nM, also inhibits ERK5 catalytic activity with IC50 of 810 nM.
-
Astex ERK inhibitor ...
Astex ERK inhibitor X is a novel potent ERK1/2 inhibitor that inhibits ERK catalytic activity with IC50 of 3 nM in TRK kinase assays.
-
Ulixertinib hydrochl...
Ulixertinib hydrochloride (Ulixertinib HCl) is an orally available, selective and potent ERK1/2 inhibitor with anticancer and antitumor activity that inhibits the NB cell cycle and promotes apoptosis, and may be used in the study of solid tumors.
